Department of Ophthalmology, Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, MA United States.
Semin Ophthalmol. 2021 Nov 17;36(8):772-786. doi: 10.1080/08820538.2021.1903513. Epub 2021 Jul 23.
Interest in micro-invasive glaucoma surgery (MIGS) has exploded over the last 8 years with an increase in MIGS procedures of at least 400% in the United States, according to Medicare data. MIGS is an umbrella term that can cover many different types of surgeries. This review focuses on peer-reviewed evidence for Trabectome, iStent , Kahook Dual Blade, XEN Gel Stent, and Hydrus.
We present key recent studies evaluating the efficacy and safety of MIGS in various types of glaucoma patients with different stages of disease.
We conclude that MIGS is generally safe and efficacious, although only some MIGS have been studied through randomized clinical trials. When comparing and contrasting the different MIGS procedures, large prospective studies are not yet the norm. High-quality large prospective studies involving MIGS will be an important next step as ophthalmologists decide how to incorporate MIGS into their surgical armamentarium.
根据医疗保险数据，在过去的 8 年中，微创青光眼手术（MIGS）的关注度呈爆炸式增长，美国的 MIGS 手术数量至少增加了 400%。MIGS 是一个总称，可以涵盖许多不同类型的手术。本综述重点介绍了 Trabectome、iStent、Kahook Dual Blade、XEN 凝胶支架和 Hydrus 的同行评议证据。
我们介绍了评估 MIGS 在不同类型青光眼患者不同疾病阶段中的疗效和安全性的最新关键研究。
我们得出的结论是，MIGS 通常是安全有效的，尽管只有一些 MIGS 通过随机临床试验进行了研究。在比较和对比不同的 MIGS 手术时，大型前瞻性研究尚不是常规。涉及 MIGS 的高质量大型前瞻性研究将是眼科医生决定如何将 MIGS 纳入其手术手段的重要下一步。
